Background: Stroke is the leading cause of adult long-term disability in Western countries. Intravenous thrombolytic therapy with recombinant tissue plasminogen activator is safe and effective within the first 4.5 h after the onset of stroke. Various factors delaying acute stroke care have been iden...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!